nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCB1—Mitomycin—urinary bladder cancer	0.098	0.166	CbGbCtD
Spironolactone—ABCC2—Carboplatin—urinary bladder cancer	0.0736	0.125	CbGbCtD
Spironolactone—ABCC2—Cisplatin—urinary bladder cancer	0.0629	0.107	CbGbCtD
Spironolactone—ABCC2—Etoposide—urinary bladder cancer	0.0618	0.105	CbGbCtD
Spironolactone—SLCO1A2—Methotrexate—urinary bladder cancer	0.0492	0.0835	CbGbCtD
Spironolactone—ABCC2—Doxorubicin—urinary bladder cancer	0.0421	0.0715	CbGbCtD
Spironolactone—ABCC2—Methotrexate—urinary bladder cancer	0.0408	0.0692	CbGbCtD
Spironolactone—CYP2C8—Fluorouracil—urinary bladder cancer	0.0356	0.0605	CbGbCtD
Spironolactone—CYP2C8—Etoposide—urinary bladder cancer	0.0297	0.0505	CbGbCtD
Spironolactone—ABCB1—Gemcitabine—urinary bladder cancer	0.0282	0.0478	CbGbCtD
Spironolactone—AR—scrotum—urinary bladder cancer	0.0207	0.183	CbGeAlD
Spironolactone—ABCB1—Cisplatin—urinary bladder cancer	0.0205	0.0348	CbGbCtD
Spironolactone—ABCB1—Etoposide—urinary bladder cancer	0.0201	0.0342	CbGbCtD
Spironolactone—ABCB1—Doxorubicin—urinary bladder cancer	0.0137	0.0233	CbGbCtD
Spironolactone—ABCB1—Methotrexate—urinary bladder cancer	0.0133	0.0226	CbGbCtD
Spironolactone—AR—penis—urinary bladder cancer	0.00935	0.0828	CbGeAlD
Spironolactone—CYP11B2—renal system—urinary bladder cancer	0.00466	0.0412	CbGeAlD
Spironolactone—NR3C1—urine—urinary bladder cancer	0.00451	0.0399	CbGeAlD
Spironolactone—SHBG—prostate gland—urinary bladder cancer	0.00311	0.0275	CbGeAlD
Spironolactone—NR3C2—prostate gland—urinary bladder cancer	0.00302	0.0267	CbGeAlD
Spironolactone—PGR—prostate gland—urinary bladder cancer	0.0028	0.0248	CbGeAlD
Spironolactone—NR3C2—seminal vesicle—urinary bladder cancer	0.00255	0.0226	CbGeAlD
Spironolactone—ABCC2—prostate gland—urinary bladder cancer	0.00241	0.0213	CbGeAlD
Spironolactone—AR—prostate gland—urinary bladder cancer	0.00223	0.0198	CbGeAlD
Spironolactone—CYP11B2—lymph node—urinary bladder cancer	0.00218	0.0193	CbGeAlD
Spironolactone—NR3C2—smooth muscle tissue—urinary bladder cancer	0.00214	0.0189	CbGeAlD
Spironolactone—PGR—epithelium—urinary bladder cancer	0.00206	0.0182	CbGeAlD
Spironolactone—NR3C2—renal system—urinary bladder cancer	0.00206	0.0182	CbGeAlD
Spironolactone—NR3C2—urethra—urinary bladder cancer	0.00202	0.0179	CbGeAlD
Spironolactone—PGR—smooth muscle tissue—urinary bladder cancer	0.00199	0.0176	CbGeAlD
Spironolactone—AR—seminal vesicle—urinary bladder cancer	0.00189	0.0167	CbGeAlD
Spironolactone—SLCO1A2—renal system—urinary bladder cancer	0.00176	0.0156	CbGeAlD
Spironolactone—SHBG—female reproductive system—urinary bladder cancer	0.0017	0.015	CbGeAlD
Spironolactone—NR3C2—female reproductive system—urinary bladder cancer	0.00165	0.0146	CbGeAlD
Spironolactone—ABCC2—renal system—urinary bladder cancer	0.00164	0.0145	CbGeAlD
Spironolactone—AR—epithelium—urinary bladder cancer	0.00164	0.0145	CbGeAlD
Spironolactone—NR3C1—prostate gland—urinary bladder cancer	0.00162	0.0143	CbGeAlD
Spironolactone—AR—smooth muscle tissue—urinary bladder cancer	0.00158	0.014	CbGeAlD
Spironolactone—SHBG—vagina—urinary bladder cancer	0.00154	0.0136	CbGeAlD
Spironolactone—PGR—female reproductive system—urinary bladder cancer	0.00153	0.0135	CbGeAlD
Spironolactone—AR—renal system—urinary bladder cancer	0.00152	0.0135	CbGeAlD
Spironolactone—AR—urethra—urinary bladder cancer	0.0015	0.0132	CbGeAlD
Spironolactone—NR3C2—vagina—urinary bladder cancer	0.00149	0.0132	CbGeAlD
Spironolactone—PGR—vagina—urinary bladder cancer	0.00138	0.0122	CbGeAlD
Spironolactone—NR3C1—seminal vesicle—urinary bladder cancer	0.00137	0.0121	CbGeAlD
Spironolactone—ABCC2—female reproductive system—urinary bladder cancer	0.00131	0.0116	CbGeAlD
Spironolactone—CYP2C8—renal system—urinary bladder cancer	0.00123	0.0109	CbGeAlD
Spironolactone—AR—female reproductive system—urinary bladder cancer	0.00122	0.0108	CbGeAlD
Spironolactone—NR3C1—epithelium—urinary bladder cancer	0.00119	0.0105	CbGeAlD
Spironolactone—NR3C1—smooth muscle tissue—urinary bladder cancer	0.00115	0.0101	CbGeAlD
Spironolactone—AR—vagina—urinary bladder cancer	0.0011	0.00976	CbGeAlD
Spironolactone—NR3C1—renal system—urinary bladder cancer	0.0011	0.00976	CbGeAlD
Spironolactone—NR3C1—urethra—urinary bladder cancer	0.00108	0.00959	CbGeAlD
Spironolactone—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00106	0.0075	CcSEcCtD
Spironolactone—Ataxia—Thiotepa—urinary bladder cancer	0.00104	0.00737	CcSEcCtD
Spironolactone—Dizziness—Valrubicin—urinary bladder cancer	0.00104	0.00736	CcSEcCtD
Spironolactone—Vomiting—Valrubicin—urinary bladder cancer	0.001	0.00707	CcSEcCtD
Spironolactone—Rash—Valrubicin—urinary bladder cancer	0.000992	0.00701	CcSEcCtD
Spironolactone—Dermatitis—Valrubicin—urinary bladder cancer	0.000991	0.00701	CcSEcCtD
Spironolactone—CYP2C8—female reproductive system—urinary bladder cancer	0.000986	0.00873	CbGeAlD
Spironolactone—Headache—Valrubicin—urinary bladder cancer	0.000985	0.00697	CcSEcCtD
Spironolactone—Somnolence—Mitomycin—urinary bladder cancer	0.000963	0.00681	CcSEcCtD
Spironolactone—NR3C2—lymph node—urinary bladder cancer	0.000963	0.00852	CbGeAlD
Spironolactone—Renal failure acute—Cisplatin—urinary bladder cancer	0.000941	0.00666	CcSEcCtD
Spironolactone—Lethargy—Fluorouracil—urinary bladder cancer	0.000936	0.00662	CcSEcCtD
Spironolactone—Nausea—Valrubicin—urinary bladder cancer	0.000934	0.00661	CcSEcCtD
Spironolactone—PGR—lymph node—urinary bladder cancer	0.000895	0.00792	CbGeAlD
Spironolactone—Feeling abnormal—Mitomycin—urinary bladder cancer	0.000893	0.00632	CcSEcCtD
Spironolactone—CYP2C8—vagina—urinary bladder cancer	0.000892	0.00789	CbGeAlD
Spironolactone—NR3C1—female reproductive system—urinary bladder cancer	0.000883	0.00781	CbGeAlD
Spironolactone—ABCB1—prostate gland—urinary bladder cancer	0.000866	0.00766	CbGeAlD
Spironolactone—Ataxia—Fluorouracil—urinary bladder cancer	0.000862	0.0061	CcSEcCtD
Spironolactone—Body temperature increased—Mitomycin—urinary bladder cancer	0.000856	0.00606	CcSEcCtD
Spironolactone—Renal failure—Thiotepa—urinary bladder cancer	0.00084	0.00594	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Gemcitabine—urinary bladder cancer	0.00084	0.00594	CcSEcCtD
Spironolactone—Rash erythematous—Epirubicin—urinary bladder cancer	0.000803	0.00568	CcSEcCtD
Spironolactone—NR3C1—vagina—urinary bladder cancer	0.000799	0.00707	CbGeAlD
Spironolactone—Agranulocytosis—Thiotepa—urinary bladder cancer	0.000797	0.00564	CcSEcCtD
Spironolactone—Eosinophilia—Fluorouracil—urinary bladder cancer	0.000785	0.00555	CcSEcCtD
Spironolactone—Cramp muscle—Cisplatin—urinary bladder cancer	0.000783	0.00554	CcSEcCtD
Spironolactone—ABCC2—lymph node—urinary bladder cancer	0.000769	0.00681	CbGeAlD
Spironolactone—Rash erythematous—Doxorubicin—urinary bladder cancer	0.000743	0.00526	CcSEcCtD
Spironolactone—Diarrhoea—Mitomycin—urinary bladder cancer	0.000741	0.00524	CcSEcCtD
Spironolactone—ABCB1—seminal vesicle—urinary bladder cancer	0.000733	0.00648	CbGeAlD
Spironolactone—Toxic epidermal necrolysis—Etoposide—urinary bladder cancer	0.000717	0.00507	CcSEcCtD
Spironolactone—Cramp muscle—Etoposide—urinary bladder cancer	0.000717	0.00507	CcSEcCtD
Spironolactone—Dizziness—Mitomycin—urinary bladder cancer	0.000716	0.00507	CcSEcCtD
Spironolactone—AR—lymph node—urinary bladder cancer	0.000713	0.00631	CbGeAlD
Spironolactone—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.000712	0.00504	CcSEcCtD
Spironolactone—Renal failure—Gemcitabine—urinary bladder cancer	0.000706	0.005	CcSEcCtD
Spironolactone—Breast pain—Epirubicin—urinary bladder cancer	0.000705	0.00499	CcSEcCtD
Spironolactone—Amenorrhoea—Epirubicin—urinary bladder cancer	0.0007	0.00495	CcSEcCtD
Spironolactone—Ulcer—Methotrexate—urinary bladder cancer	0.000695	0.00491	CcSEcCtD
Spironolactone—Vomiting—Mitomycin—urinary bladder cancer	0.000689	0.00487	CcSEcCtD
Spironolactone—Rash—Mitomycin—urinary bladder cancer	0.000683	0.00483	CcSEcCtD
Spironolactone—Dermatitis—Mitomycin—urinary bladder cancer	0.000682	0.00483	CcSEcCtD
Spironolactone—Headache—Mitomycin—urinary bladder cancer	0.000679	0.0048	CcSEcCtD
Spironolactone—Alopecia—Thiotepa—urinary bladder cancer	0.000678	0.00479	CcSEcCtD
Spironolactone—Vasculitis—Methotrexate—urinary bladder cancer	0.000673	0.00476	CcSEcCtD
Spironolactone—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.000671	0.00474	CcSEcCtD
Spironolactone—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.000659	0.00466	CcSEcCtD
Spironolactone—Renal failure—Cisplatin—urinary bladder cancer	0.000658	0.00466	CcSEcCtD
Spironolactone—Breast pain—Doxorubicin—urinary bladder cancer	0.000652	0.00461	CcSEcCtD
Spironolactone—Ulcer—Epirubicin—urinary bladder cancer	0.00065	0.0046	CcSEcCtD
Spironolactone—Amenorrhoea—Doxorubicin—urinary bladder cancer	0.000648	0.00458	CcSEcCtD
Spironolactone—Nausea—Mitomycin—urinary bladder cancer	0.000644	0.00455	CcSEcCtD
Spironolactone—ABCB1—epithelium—urinary bladder cancer	0.000636	0.00563	CbGeAlD
Spironolactone—Fluoxymesterone—ESR1—urinary bladder cancer	0.000626	0.334	CrCbGaD
Spironolactone—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.00061	0.00431	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.000608	0.0043	CcSEcCtD
Spironolactone—Hyperkalaemia—Epirubicin—urinary bladder cancer	0.000604	0.00427	CcSEcCtD
Spironolactone—Renal failure—Etoposide—urinary bladder cancer	0.000603	0.00427	CcSEcCtD
Spironolactone—Ulcer—Doxorubicin—urinary bladder cancer	0.000602	0.00426	CcSEcCtD
Spironolactone—Leukopenia—Thiotepa—urinary bladder cancer	0.000598	0.00423	CcSEcCtD
Spironolactone—ABCB1—renal system—urinary bladder cancer	0.00059	0.00522	CbGeAlD
Spironolactone—Gynaecomastia—Methotrexate—urinary bladder cancer	0.000588	0.00416	CcSEcCtD
Spironolactone—ABCB1—urethra—urinary bladder cancer	0.00058	0.00513	CbGeAlD
Spironolactone—Agranulocytosis—Etoposide—urinary bladder cancer	0.000573	0.00405	CcSEcCtD
Spironolactone—Alopecia—Gemcitabine—urinary bladder cancer	0.00057	0.00403	CcSEcCtD
Spironolactone—Cramps of lower extremities—Epirubicin—urinary bladder cancer	0.000565	0.004	CcSEcCtD
Spironolactone—Alopecia—Fluorouracil—urinary bladder cancer	0.000561	0.00397	CcSEcCtD
Spironolactone—Hyperkalaemia—Doxorubicin—urinary bladder cancer	0.000559	0.00395	CcSEcCtD
Spironolactone—Confusional state—Thiotepa—urinary bladder cancer	0.000549	0.00389	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—ESR1—urinary bladder cancer	0.000537	0.286	CrCbGaD
Spironolactone—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000533	0.00377	CcSEcCtD
Spironolactone—Alopecia—Cisplatin—urinary bladder cancer	0.000531	0.00376	CcSEcCtD
Spironolactone—Cramps of lower extremities—Doxorubicin—urinary bladder cancer	0.000523	0.0037	CcSEcCtD
Spironolactone—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000521	0.00369	CcSEcCtD
Spironolactone—Erythema multiforme—Etoposide—urinary bladder cancer	0.000521	0.00368	CcSEcCtD
Spironolactone—Renal failure acute—Methotrexate—urinary bladder cancer	0.000517	0.00365	CcSEcCtD
Spironolactone—NR3C1—lymph node—urinary bladder cancer	0.000517	0.00457	CbGeAlD
Spironolactone—Malaise—Gemcitabine—urinary bladder cancer	0.000506	0.00358	CcSEcCtD
Spironolactone—Muscle spasms—Cisplatin—urinary bladder cancer	0.000503	0.00356	CcSEcCtD
Spironolactone—Leukopenia—Gemcitabine—urinary bladder cancer	0.000503	0.00356	CcSEcCtD
Spironolactone—Leukopenia—Fluorouracil—urinary bladder cancer	0.000494	0.0035	CcSEcCtD
Spironolactone—Alopecia—Etoposide—urinary bladder cancer	0.000487	0.00344	CcSEcCtD
Spironolactone—Lethargy—Methotrexate—urinary bladder cancer	0.000487	0.00344	CcSEcCtD
Spironolactone—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000486	0.00344	CcSEcCtD
Spironolactone—Somnolence—Thiotepa—urinary bladder cancer	0.000484	0.00343	CcSEcCtD
Spironolactone—Renal failure acute—Epirubicin—urinary bladder cancer	0.000483	0.00342	CcSEcCtD
Spironolactone—ABCB1—female reproductive system—urinary bladder cancer	0.000473	0.00418	CbGeAlD
Spironolactone—Discomfort—Gemcitabine—urinary bladder cancer	0.000472	0.00334	CcSEcCtD
Spironolactone—Malaise—Cisplatin—urinary bladder cancer	0.000472	0.00334	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00047	0.00333	CcSEcCtD
Spironolactone—Leukopenia—Cisplatin—urinary bladder cancer	0.000469	0.00331	CcSEcCtD
Spironolactone—Discomfort—Fluorouracil—urinary bladder cancer	0.000464	0.00329	CcSEcCtD
Spironolactone—Muscle spasms—Etoposide—urinary bladder cancer	0.000461	0.00326	CcSEcCtD
Spironolactone—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000458	0.00324	CcSEcCtD
Spironolactone—Lethargy—Epirubicin—urinary bladder cancer	0.000456	0.00322	CcSEcCtD
Spironolactone—Confusional state—Fluorouracil—urinary bladder cancer	0.000454	0.00321	CcSEcCtD
Spironolactone—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000451	0.00319	CcSEcCtD
Spironolactone—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000449	0.00318	CcSEcCtD
Spironolactone—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000449	0.00317	CcSEcCtD
Spironolactone—Ataxia—Methotrexate—urinary bladder cancer	0.000448	0.00317	CcSEcCtD
Spironolactone—Renal failure acute—Doxorubicin—urinary bladder cancer	0.000447	0.00316	CcSEcCtD
Spironolactone—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000445	0.00315	CcSEcCtD
Spironolactone—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000441	0.00312	CcSEcCtD
Spironolactone—Discomfort—Cisplatin—urinary bladder cancer	0.00044	0.00311	CcSEcCtD
Spironolactone—Urticaria—Thiotepa—urinary bladder cancer	0.000433	0.00306	CcSEcCtD
Spironolactone—Malaise—Etoposide—urinary bladder cancer	0.000432	0.00306	CcSEcCtD
Spironolactone—Body temperature increased—Thiotepa—urinary bladder cancer	0.000431	0.00305	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00043	0.00304	CcSEcCtD
Spironolactone—Leukopenia—Etoposide—urinary bladder cancer	0.000429	0.00304	CcSEcCtD
Spironolactone—ABCB1—vagina—urinary bladder cancer	0.000428	0.00378	CbGeAlD
Spironolactone—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000427	0.00302	CcSEcCtD
Spironolactone—Lethargy—Doxorubicin—urinary bladder cancer	0.000421	0.00298	CcSEcCtD
Spironolactone—Ataxia—Epirubicin—urinary bladder cancer	0.00042	0.00297	CcSEcCtD
Spironolactone—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000418	0.00296	CcSEcCtD
Spironolactone—Eosinophilia—Methotrexate—urinary bladder cancer	0.000408	0.00289	CcSEcCtD
Spironolactone—Somnolence—Gemcitabine—urinary bladder cancer	0.000407	0.00288	CcSEcCtD
Spironolactone—Discomfort—Etoposide—urinary bladder cancer	0.000403	0.00285	CcSEcCtD
Spironolactone—Drospirenone—PTGS2—urinary bladder cancer	0.000402	0.214	CrCbGaD
Spironolactone—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000402	0.00284	CcSEcCtD
Spironolactone—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000401	0.00284	CcSEcCtD
Spironolactone—Somnolence—Fluorouracil—urinary bladder cancer	0.000401	0.00283	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000396	0.0028	CcSEcCtD
Spironolactone—Gastritis—Epirubicin—urinary bladder cancer	0.000395	0.00279	CcSEcCtD
Spironolactone—Confusional state—Etoposide—urinary bladder cancer	0.000395	0.00279	CcSEcCtD
Spironolactone—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000391	0.00277	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000389	0.00275	CcSEcCtD
Spironolactone—Ataxia—Doxorubicin—urinary bladder cancer	0.000388	0.00275	CcSEcCtD
Spironolactone—Pruritus—Thiotepa—urinary bladder cancer	0.000385	0.00273	CcSEcCtD
Spironolactone—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000383	0.00271	CcSEcCtD
Spironolactone—Eosinophilia—Epirubicin—urinary bladder cancer	0.000382	0.0027	CcSEcCtD
Spironolactone—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00038	0.00269	CcSEcCtD
Spironolactone—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000378	0.00267	CcSEcCtD
Spironolactone—Diarrhoea—Thiotepa—urinary bladder cancer	0.000373	0.00264	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000372	0.00263	CcSEcCtD
Spironolactone—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000371	0.00263	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000369	0.00261	CcSEcCtD
Spironolactone—Drowsiness—Methotrexate—urinary bladder cancer	0.000368	0.0026	CcSEcCtD
Spironolactone—Gastritis—Doxorubicin—urinary bladder cancer	0.000366	0.00259	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000364	0.00258	CcSEcCtD
Spironolactone—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000362	0.00256	CcSEcCtD
Spironolactone—Renal failure—Methotrexate—urinary bladder cancer	0.000361	0.00256	CcSEcCtD
Spironolactone—Dizziness—Thiotepa—urinary bladder cancer	0.00036	0.00255	CcSEcCtD
Spironolactone—Urticaria—Fluorouracil—urinary bladder cancer	0.000358	0.00253	CcSEcCtD
Spironolactone—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000356	0.00252	CcSEcCtD
Spironolactone—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000353	0.0025	CcSEcCtD
Spironolactone—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000352	0.00249	CcSEcCtD
Spironolactone—Somnolence—Etoposide—urinary bladder cancer	0.000348	0.00246	CcSEcCtD
Spironolactone—Vomiting—Thiotepa—urinary bladder cancer	0.000346	0.00245	CcSEcCtD
Spironolactone—Drowsiness—Epirubicin—urinary bladder cancer	0.000344	0.00243	CcSEcCtD
Spironolactone—Rash—Thiotepa—urinary bladder cancer	0.000344	0.00243	CcSEcCtD
Spironolactone—Dermatitis—Thiotepa—urinary bladder cancer	0.000343	0.00243	CcSEcCtD
Spironolactone—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000343	0.00243	CcSEcCtD
Spironolactone—Headache—Thiotepa—urinary bladder cancer	0.000341	0.00241	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000341	0.00241	CcSEcCtD
Spironolactone—Renal failure—Epirubicin—urinary bladder cancer	0.000338	0.00239	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000338	0.00239	CcSEcCtD
Spironolactone—Body temperature increased—Cisplatin—urinary bladder cancer	0.000338	0.00239	CcSEcCtD
Spironolactone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000332	0.00235	CcSEcCtD
Spironolactone—Pruritus—Gemcitabine—urinary bladder cancer	0.000324	0.00229	CcSEcCtD
Spironolactone—Nausea—Thiotepa—urinary bladder cancer	0.000324	0.00229	CcSEcCtD
Spironolactone—Feeling abnormal—Etoposide—urinary bladder cancer	0.000323	0.00228	CcSEcCtD
Spironolactone—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000321	0.00227	CcSEcCtD
Spironolactone—Pruritus—Fluorouracil—urinary bladder cancer	0.000319	0.00226	CcSEcCtD
Spironolactone—Drowsiness—Doxorubicin—urinary bladder cancer	0.000318	0.00225	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000316	0.00223	CcSEcCtD
Spironolactone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000315	0.00223	CcSEcCtD
Spironolactone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000314	0.00222	CcSEcCtD
Spironolactone—Renal failure—Doxorubicin—urinary bladder cancer	0.000313	0.00221	CcSEcCtD
Spironolactone—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000312	0.00221	CcSEcCtD
Spironolactone—Urticaria—Etoposide—urinary bladder cancer	0.000311	0.0022	CcSEcCtD
Spironolactone—Progesterone—ESR1—urinary bladder cancer	0.00031	0.165	CrCbGaD
Spironolactone—Body temperature increased—Etoposide—urinary bladder cancer	0.000309	0.00219	CcSEcCtD
Spironolactone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000308	0.00218	CcSEcCtD
Spironolactone—Dizziness—Fluorouracil—urinary bladder cancer	0.000298	0.00211	CcSEcCtD
Spironolactone—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000297	0.0021	CcSEcCtD
Spironolactone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000292	0.00207	CcSEcCtD
Spironolactone—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000292	0.00207	CcSEcCtD
Spironolactone—Alopecia—Methotrexate—urinary bladder cancer	0.000292	0.00206	CcSEcCtD
Spironolactone—Vomiting—Gemcitabine—urinary bladder cancer	0.000291	0.00206	CcSEcCtD
Spironolactone—Rash—Gemcitabine—urinary bladder cancer	0.000289	0.00204	CcSEcCtD
Spironolactone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000289	0.00204	CcSEcCtD
Spironolactone—Hypersensitivity—Etoposide—urinary bladder cancer	0.000288	0.00204	CcSEcCtD
Spironolactone—Headache—Gemcitabine—urinary bladder cancer	0.000287	0.00203	CcSEcCtD
Spironolactone—Vomiting—Fluorouracil—urinary bladder cancer	0.000287	0.00203	CcSEcCtD
Spironolactone—Rash—Fluorouracil—urinary bladder cancer	0.000284	0.00201	CcSEcCtD
Spironolactone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000284	0.00201	CcSEcCtD
Spironolactone—Headache—Fluorouracil—urinary bladder cancer	0.000282	0.002	CcSEcCtD
Spironolactone—Pruritus—Etoposide—urinary bladder cancer	0.000277	0.00196	CcSEcCtD
Spironolactone—ABCB1—lymph node—urinary bladder cancer	0.000277	0.00245	CbGeAlD
Spironolactone—Alopecia—Epirubicin—urinary bladder cancer	0.000273	0.00193	CcSEcCtD
Spironolactone—Nausea—Gemcitabine—urinary bladder cancer	0.000272	0.00193	CcSEcCtD
Spironolactone—Vomiting—Cisplatin—urinary bladder cancer	0.000272	0.00192	CcSEcCtD
Spironolactone—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00027	0.00191	CcSEcCtD
Spironolactone—Rash—Cisplatin—urinary bladder cancer	0.000269	0.00191	CcSEcCtD
Spironolactone—Dermatitis—Cisplatin—urinary bladder cancer	0.000269	0.0019	CcSEcCtD
Spironolactone—Diarrhoea—Etoposide—urinary bladder cancer	0.000268	0.00189	CcSEcCtD
Spironolactone—Nausea—Fluorouracil—urinary bladder cancer	0.000268	0.00189	CcSEcCtD
Spironolactone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000267	0.00189	CcSEcCtD
Spironolactone—Malaise—Methotrexate—urinary bladder cancer	0.000259	0.00183	CcSEcCtD
Spironolactone—Dizziness—Etoposide—urinary bladder cancer	0.000259	0.00183	CcSEcCtD
Spironolactone—Muscle spasms—Epirubicin—urinary bladder cancer	0.000258	0.00183	CcSEcCtD
Spironolactone—Leukopenia—Methotrexate—urinary bladder cancer	0.000257	0.00182	CcSEcCtD
Spironolactone—Nausea—Cisplatin—urinary bladder cancer	0.000254	0.0018	CcSEcCtD
Spironolactone—Alopecia—Doxorubicin—urinary bladder cancer	0.000252	0.00179	CcSEcCtD
Spironolactone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000249	0.00176	CcSEcCtD
Spironolactone—Vomiting—Etoposide—urinary bladder cancer	0.000249	0.00176	CcSEcCtD
Spironolactone—Rash—Etoposide—urinary bladder cancer	0.000247	0.00175	CcSEcCtD
Spironolactone—Dermatitis—Etoposide—urinary bladder cancer	0.000247	0.00174	CcSEcCtD
Spironolactone—Headache—Etoposide—urinary bladder cancer	0.000245	0.00173	CcSEcCtD
Spironolactone—Malaise—Epirubicin—urinary bladder cancer	0.000242	0.00171	CcSEcCtD
Spironolactone—Discomfort—Methotrexate—urinary bladder cancer	0.000242	0.00171	CcSEcCtD
Spironolactone—Leukopenia—Epirubicin—urinary bladder cancer	0.000241	0.0017	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000239	0.00169	CcSEcCtD
Spironolactone—Confusional state—Methotrexate—urinary bladder cancer	0.000236	0.00167	CcSEcCtD
Spironolactone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000234	0.00166	CcSEcCtD
Spironolactone—Nausea—Etoposide—urinary bladder cancer	0.000232	0.00164	CcSEcCtD
Spironolactone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000231	0.00163	CcSEcCtD
Spironolactone—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00023	0.00162	CcSEcCtD
Spironolactone—Discomfort—Epirubicin—urinary bladder cancer	0.000226	0.0016	CcSEcCtD
Spironolactone—Malaise—Doxorubicin—urinary bladder cancer	0.000224	0.00159	CcSEcCtD
Spironolactone—Leukopenia—Doxorubicin—urinary bladder cancer	0.000223	0.00157	CcSEcCtD
Spironolactone—Confusional state—Epirubicin—urinary bladder cancer	0.000221	0.00156	CcSEcCtD
Spironolactone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000219	0.00155	CcSEcCtD
Spironolactone—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000215	0.00152	CcSEcCtD
Spironolactone—Discomfort—Doxorubicin—urinary bladder cancer	0.000209	0.00148	CcSEcCtD
Spironolactone—Somnolence—Methotrexate—urinary bladder cancer	0.000208	0.00147	CcSEcCtD
Spironolactone—Confusional state—Doxorubicin—urinary bladder cancer	0.000205	0.00145	CcSEcCtD
Spironolactone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000203	0.00144	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000202	0.00143	CcSEcCtD
Spironolactone—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000199	0.00141	CcSEcCtD
Spironolactone—Somnolence—Epirubicin—urinary bladder cancer	0.000195	0.00138	CcSEcCtD
Spironolactone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000193	0.00137	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000189	0.00134	CcSEcCtD
Spironolactone—Urticaria—Methotrexate—urinary bladder cancer	0.000186	0.00132	CcSEcCtD
Spironolactone—Body temperature increased—Methotrexate—urinary bladder cancer	0.000185	0.00131	CcSEcCtD
Spironolactone—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000181	0.00128	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—urinary bladder cancer	0.00018	0.00128	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000175	0.00124	CcSEcCtD
Spironolactone—Urticaria—Epirubicin—urinary bladder cancer	0.000174	0.00123	CcSEcCtD
Spironolactone—Body temperature increased—Epirubicin—urinary bladder cancer	0.000173	0.00123	CcSEcCtD
Spironolactone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000173	0.00122	CcSEcCtD
Spironolactone—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000167	0.00118	CcSEcCtD
Spironolactone—Pruritus—Methotrexate—urinary bladder cancer	0.000166	0.00117	CcSEcCtD
Spironolactone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000162	0.00114	CcSEcCtD
Spironolactone—Urticaria—Doxorubicin—urinary bladder cancer	0.000161	0.00114	CcSEcCtD
Spironolactone—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00016	0.00114	CcSEcCtD
Spironolactone—Diarrhoea—Methotrexate—urinary bladder cancer	0.00016	0.00113	CcSEcCtD
Spironolactone—Pruritus—Epirubicin—urinary bladder cancer	0.000155	0.0011	CcSEcCtD
Spironolactone—Dizziness—Methotrexate—urinary bladder cancer	0.000155	0.0011	CcSEcCtD
Spironolactone—Diarrhoea—Epirubicin—urinary bladder cancer	0.00015	0.00106	CcSEcCtD
Spironolactone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00015	0.00106	CcSEcCtD
Spironolactone—Vomiting—Methotrexate—urinary bladder cancer	0.000149	0.00105	CcSEcCtD
Spironolactone—Rash—Methotrexate—urinary bladder cancer	0.000148	0.00105	CcSEcCtD
Spironolactone—Dermatitis—Methotrexate—urinary bladder cancer	0.000148	0.00104	CcSEcCtD
Spironolactone—Headache—Methotrexate—urinary bladder cancer	0.000147	0.00104	CcSEcCtD
Spironolactone—Dizziness—Epirubicin—urinary bladder cancer	0.000145	0.00103	CcSEcCtD
Spironolactone—Pruritus—Doxorubicin—urinary bladder cancer	0.000144	0.00102	CcSEcCtD
Spironolactone—Vomiting—Epirubicin—urinary bladder cancer	0.000139	0.000987	CcSEcCtD
Spironolactone—Nausea—Methotrexate—urinary bladder cancer	0.000139	0.000985	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000139	0.000983	CcSEcCtD
Spironolactone—Rash—Epirubicin—urinary bladder cancer	0.000138	0.000979	CcSEcCtD
Spironolactone—Dermatitis—Epirubicin—urinary bladder cancer	0.000138	0.000978	CcSEcCtD
Spironolactone—Headache—Epirubicin—urinary bladder cancer	0.000137	0.000972	CcSEcCtD
Spironolactone—Dizziness—Doxorubicin—urinary bladder cancer	0.000134	0.00095	CcSEcCtD
Spironolactone—Nausea—Epirubicin—urinary bladder cancer	0.00013	0.000922	CcSEcCtD
Spironolactone—Vomiting—Doxorubicin—urinary bladder cancer	0.000129	0.000913	CcSEcCtD
Spironolactone—Rash—Doxorubicin—urinary bladder cancer	0.000128	0.000905	CcSEcCtD
Spironolactone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000128	0.000905	CcSEcCtD
Spironolactone—Headache—Doxorubicin—urinary bladder cancer	0.000127	0.0009	CcSEcCtD
Spironolactone—Nausea—Doxorubicin—urinary bladder cancer	0.000121	0.000853	CcSEcCtD
Spironolactone—NR3C1—Adipogenesis—CDKN1A—urinary bladder cancer	8.41e-05	0.000545	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.37e-05	0.000543	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.37e-05	0.000543	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—HRAS—urinary bladder cancer	8.36e-05	0.000542	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.29e-05	0.000538	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—urinary bladder cancer	8.28e-05	0.000537	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—NCOR1—urinary bladder cancer	8.21e-05	0.000533	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PRSS3—urinary bladder cancer	8.2e-05	0.000532	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	8.17e-05	0.00053	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—RRM2—urinary bladder cancer	8.16e-05	0.000529	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	8.15e-05	0.000529	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	8.15e-05	0.000528	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	8.13e-05	0.000527	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—ESR2—urinary bladder cancer	8.07e-05	0.000523	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	8.06e-05	0.000523	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—ERCC2—urinary bladder cancer	8.01e-05	0.00052	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	7.97e-05	0.000517	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	7.75e-05	0.000503	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—PPARG—urinary bladder cancer	7.72e-05	0.000501	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—SMC1A—urinary bladder cancer	7.71e-05	0.0005	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ENO2—urinary bladder cancer	7.56e-05	0.00049	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—HPGDS—urinary bladder cancer	7.56e-05	0.00049	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GLI1—urinary bladder cancer	7.55e-05	0.00049	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	7.54e-05	0.000489	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	7.53e-05	0.000489	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.51e-05	0.000487	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	7.47e-05	0.000484	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	7.42e-05	0.000481	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	7.4e-05	0.00048	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	7.39e-05	0.00048	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTT1—urinary bladder cancer	7.33e-05	0.000475	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—MYC—urinary bladder cancer	7.23e-05	0.000469	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.22e-05	0.000468	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	7.15e-05	0.000464	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	7.13e-05	0.000463	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NQO1—urinary bladder cancer	7.07e-05	0.000458	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	6.94e-05	0.00045	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	6.91e-05	0.000449	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.86e-05	0.000445	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	6.82e-05	0.000442	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	6.75e-05	0.000438	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ESR2—urinary bladder cancer	6.72e-05	0.000436	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	6.69e-05	0.000434	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—ESR1—urinary bladder cancer	6.69e-05	0.000434	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	6.61e-05	0.000429	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.57e-05	0.000426	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TYMP—urinary bladder cancer	6.55e-05	0.000425	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TNF—urinary bladder cancer	6.49e-05	0.000421	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—ESR1—urinary bladder cancer	6.45e-05	0.000418	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.29e-05	0.000408	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	6.29e-05	0.000408	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	6.24e-05	0.000405	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	6.23e-05	0.000404	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—PPARG—urinary bladder cancer	6.11e-05	0.000396	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NQO1—urinary bladder cancer	6.09e-05	0.000395	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	6.04e-05	0.000392	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.98e-05	0.000388	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NAT2—urinary bladder cancer	5.93e-05	0.000384	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.91e-05	0.000383	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GSTP1—urinary bladder cancer	5.89e-05	0.000382	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—PPARG—urinary bladder cancer	5.89e-05	0.000382	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SMC1A—urinary bladder cancer	5.88e-05	0.000381	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—CREBBP—urinary bladder cancer	5.87e-05	0.000381	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	5.83e-05	0.000378	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.7e-05	0.00037	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	5.65e-05	0.000367	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	5.61e-05	0.000364	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	5.61e-05	0.000364	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.55e-05	0.00036	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—TYMS—urinary bladder cancer	5.48e-05	0.000355	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NCOR1—urinary bladder cancer	5.42e-05	0.000351	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GSTM1—urinary bladder cancer	5.42e-05	0.000351	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	5.34e-05	0.000346	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	5.32e-05	0.000345	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	5.32e-05	0.000345	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NAT1—urinary bladder cancer	5.32e-05	0.000345	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	5.29e-05	0.000343	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.23e-05	0.000339	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	5.2e-05	0.000337	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NCOR1—urinary bladder cancer	5.19e-05	0.000337	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GPX1—urinary bladder cancer	5.19e-05	0.000336	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RBX1—urinary bladder cancer	5.18e-05	0.000336	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.15e-05	0.000334	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ESR2—urinary bladder cancer	5.12e-05	0.000332	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	5.12e-05	0.000332	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ERCC2—urinary bladder cancer	5.09e-05	0.00033	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTP1—urinary bladder cancer	5.08e-05	0.00033	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.91e-05	0.000319	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—ESR1—urinary bladder cancer	4.89e-05	0.000317	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	4.88e-05	0.000317	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ERCC2—urinary bladder cancer	4.88e-05	0.000316	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TSC1—urinary bladder cancer	4.87e-05	0.000316	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	4.86e-05	0.000315	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—MTHFR—urinary bladder cancer	4.79e-05	0.000311	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	4.74e-05	0.000307	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	4.74e-05	0.000307	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—TYMS—urinary bladder cancer	4.72e-05	0.000306	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.71e-05	0.000306	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTM1—urinary bladder cancer	4.67e-05	0.000303	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NCOR1—urinary bladder cancer	4.67e-05	0.000303	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	4.64e-05	0.000301	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JAG1—urinary bladder cancer	4.63e-05	0.000301	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NAT1—urinary bladder cancer	4.63e-05	0.0003	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTO2—urinary bladder cancer	4.63e-05	0.0003	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	4.6e-05	0.000298	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	4.58e-05	0.000297	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.52e-05	0.000294	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GPX1—urinary bladder cancer	4.47e-05	0.00029	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—PPARG—urinary bladder cancer	4.47e-05	0.00029	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SMC1A—urinary bladder cancer	4.46e-05	0.000289	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—MYC—urinary bladder cancer	4.4e-05	0.000286	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ERCC2—urinary bladder cancer	4.39e-05	0.000285	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	4.38e-05	0.000284	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.3e-05	0.000279	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	4.29e-05	0.000278	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	4.24e-05	0.000275	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	4.13e-05	0.000268	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—MTHFR—urinary bladder cancer	4.13e-05	0.000268	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ESR1—urinary bladder cancer	4.08e-05	0.000264	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	4.03e-05	0.000261	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NCOR1—urinary bladder cancer	3.95e-05	0.000256	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.94e-05	0.000255	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.92e-05	0.000254	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR2—urinary bladder cancer	3.89e-05	0.000252	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.88e-05	0.000252	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PPARG—urinary bladder cancer	3.88e-05	0.000252	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	3.82e-05	0.000248	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.81e-05	0.000247	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.8e-05	0.000246	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—S100B—urinary bladder cancer	3.75e-05	0.000243	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CREBBP—urinary bladder cancer	3.73e-05	0.000242	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PPARG—urinary bladder cancer	3.72e-05	0.000241	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ERCC2—urinary bladder cancer	3.72e-05	0.000241	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.71e-05	0.00024	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3.6e-05	0.000234	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—CREBBP—urinary bladder cancer	3.57e-05	0.000232	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PRSS3—urinary bladder cancer	3.51e-05	0.000228	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MYC—urinary bladder cancer	3.48e-05	0.000226	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.43e-05	0.000223	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NCOR1—urinary bladder cancer	3.37e-05	0.000219	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—urinary bladder cancer	3.36e-05	0.000218	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PPARG—urinary bladder cancer	3.35e-05	0.000217	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.32e-05	0.000215	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.31e-05	0.000215	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.23e-05	0.00021	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.23e-05	0.000209	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TYMP—urinary bladder cancer	3.22e-05	0.000209	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CREBBP—urinary bladder cancer	3.21e-05	0.000208	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	3.19e-05	0.000207	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.16e-05	0.000205	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ESR1—urinary bladder cancer	3.11e-05	0.000201	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.09e-05	0.000201	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.08e-05	0.0002	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.07e-05	0.000199	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—urinary bladder cancer	3.05e-05	0.000198	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NCOR1—urinary bladder cancer	3e-05	0.000195	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TERT—urinary bladder cancer	2.97e-05	0.000193	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	2.96e-05	0.000192	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	2.93e-05	0.00019	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	2.93e-05	0.00019	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NAT2—urinary bladder cancer	2.91e-05	0.000189	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPARG—urinary bladder cancer	2.83e-05	0.000184	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ERCC2—urinary bladder cancer	2.82e-05	0.000183	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.81e-05	0.000182	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	2.8e-05	0.000182	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.75e-05	0.000179	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	2.75e-05	0.000179	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGFR3—urinary bladder cancer	2.73e-05	0.000177	CbGpPWpGaD
Spironolactone—AR—Gene Expression—CREBBP—urinary bladder cancer	2.72e-05	0.000177	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.69e-05	0.000175	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTEN—urinary bladder cancer	2.66e-05	0.000173	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ESR1—urinary bladder cancer	2.65e-05	0.000172	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—urinary bladder cancer	2.63e-05	0.000171	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	2.59e-05	0.000168	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.56e-05	0.000166	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—urinary bladder cancer	2.55e-05	0.000165	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.54e-05	0.000165	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—EP300—urinary bladder cancer	2.54e-05	0.000165	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.54e-05	0.000165	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—RRM2—urinary bladder cancer	2.51e-05	0.000163	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR1—urinary bladder cancer	2.36e-05	0.000153	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ENO2—urinary bladder cancer	2.33e-05	0.000151	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	2.33e-05	0.000151	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CREBBP—urinary bladder cancer	2.32e-05	0.000151	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.31e-05	0.00015	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTEN—urinary bladder cancer	2.3e-05	0.000149	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1—urinary bladder cancer	2.29e-05	0.000149	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.26e-05	0.000147	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	2.26e-05	0.000146	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.22e-05	0.000144	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.19e-05	0.000142	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—EP300—urinary bladder cancer	2.19e-05	0.000142	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARG—urinary bladder cancer	2.15e-05	0.000139	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—urinary bladder cancer	2.12e-05	0.000138	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RHOA—urinary bladder cancer	2.1e-05	0.000136	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	2.1e-05	0.000136	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—CREBBP—urinary bladder cancer	2.07e-05	0.000134	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.03e-05	0.000132	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.03e-05	0.000132	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	2.02e-05	0.000131	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.97e-05	0.000128	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB2—urinary bladder cancer	1.95e-05	0.000126	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.88e-05	0.000122	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL8—urinary bladder cancer	1.84e-05	0.00012	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.84e-05	0.000119	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.82e-05	0.000118	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2—urinary bladder cancer	1.76e-05	0.000114	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—urinary bladder cancer	1.72e-05	0.000111	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—urinary bladder cancer	1.67e-05	0.000108	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1A—urinary bladder cancer	1.66e-05	0.000108	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTEN—urinary bladder cancer	1.66e-05	0.000108	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	1.65e-05	0.000107	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.63e-05	0.000106	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—urinary bladder cancer	1.62e-05	0.000105	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.59e-05	0.000103	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EP300—urinary bladder cancer	1.58e-05	0.000103	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.57e-05	0.000102	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SRC—urinary bladder cancer	1.54e-05	9.98e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.51e-05	9.82e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.46e-05	9.44e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	1.44e-05	9.33e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.44e-05	9.33e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.44e-05	9.33e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—urinary bladder cancer	1.38e-05	8.94e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.38e-05	8.93e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—EP300—urinary bladder cancer	1.37e-05	8.9e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.36e-05	8.84e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.35e-05	8.77e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—urinary bladder cancer	1.35e-05	8.75e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—urinary bladder cancer	1.27e-05	8.26e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.27e-05	8.25e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.27e-05	8.22e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.25e-05	8.13e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.25e-05	8.13e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—urinary bladder cancer	1.23e-05	7.95e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.2e-05	7.78e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.18e-05	7.64e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—urinary bladder cancer	1.13e-05	7.34e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.11e-05	7.18e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—urinary bladder cancer	1.08e-05	7.02e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.03e-05	6.69e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	9.9e-06	6.42e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARG—urinary bladder cancer	8.98e-06	5.82e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CREBBP—urinary bladder cancer	8.63e-06	5.6e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	8.11e-06	5.26e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTEN—urinary bladder cancer	7.07e-06	4.59e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—urinary bladder cancer	7.06e-06	4.58e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—EP300—urinary bladder cancer	6.74e-06	4.37e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTEN—urinary bladder cancer	6.16e-06	4e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—EP300—urinary bladder cancer	5.88e-06	3.81e-05	CbGpPWpGaD
